TaiGen Biopharmaceuticals Holdings Limited (TPEX: 4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.45
-0.10 (-0.80%)
Nov 20, 2024, 12:29 PM CST

TaiGen Biopharmaceuticals Holdings Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
209.82374.66243.11364.9360.85136.26
Upgrade
Short-Term Investments
583.97598.2591.11495.38197.22434.77
Upgrade
Trading Asset Securities
266.3565.1464.3964.0972.766.51
Upgrade
Cash & Short-Term Investments
1,0601,038898.6924.4330.78637.54
Upgrade
Cash Growth
29.19%15.51%-2.79%179.46%-48.12%-18.51%
Upgrade
Accounts Receivable
6.418.9818.41278.287.311.77
Upgrade
Other Receivables
7.2324.885.32.6128.6433.49
Upgrade
Receivables
13.6433.8723.71280.8935.9535.26
Upgrade
Inventory
48.7834.1515.3517.8814.657.52
Upgrade
Other Current Assets
4.24.3711.578.8410.2223.5
Upgrade
Total Current Assets
1,1271,110949.241,232391.6703.82
Upgrade
Property, Plant & Equipment
72.6890.6156.680.4342.4764.83
Upgrade
Long-Term Investments
5.679.7123.9853.985.86133.82
Upgrade
Other Intangible Assets
11.330.10.230.160.290.68
Upgrade
Other Long-Term Assets
6.2119.0416.9626.3136.2442.95
Upgrade
Total Assets
1,2231,2301,0471,393556.45946.11
Upgrade
Short-Term Debt
--3--30
Upgrade
Current Portion of Leases
16.2415.9818.3417.9917.1219.07
Upgrade
Current Income Taxes Payable
--3.0727.86-5.29
Upgrade
Current Unearned Revenue
0.150.150.150.1844.410.18
Upgrade
Other Current Liabilities
41.9831.7626.7643.8533.3734.78
Upgrade
Total Current Liabilities
58.3747.8951.3289.8894.9189.31
Upgrade
Long-Term Leases
46.558.7117.1335.47-17.12
Upgrade
Long-Term Unearned Revenue
0.220.330.480.620.790.97
Upgrade
Total Liabilities
108.94110.9476.98139.11114.26130.92
Upgrade
Common Stock
20.9420.9420.9120.9120.9120.91
Upgrade
Additional Paid-In Capital
460.96444.61450.26455.25675.14660.68
Upgrade
Retained Earnings
664.76678.68542.05778.3-300.21103.96
Upgrade
Comprehensive Income & Other
-32.95-25.34-43.2-0.7746.3429.64
Upgrade
Shareholders' Equity
1,1141,119970.031,254442.18815.18
Upgrade
Total Liabilities & Equity
1,2231,2301,0471,393556.45946.11
Upgrade
Total Debt
62.7474.6938.4753.4617.1266.19
Upgrade
Net Cash (Debt)
997.41963.3860.13870.94313.66571.35
Upgrade
Net Cash Growth
34.42%12.00%-1.24%177.67%-45.10%-26.97%
Upgrade
Net Cash Per Share
1.391.341.201.210.440.80
Upgrade
Filing Date Shares Outstanding
719.7717.84716.84716.84716.84716.84
Upgrade
Total Common Shares Outstanding
719.7717.84716.84716.84716.84716.84
Upgrade
Working Capital
1,0681,062897.921,142296.69614.51
Upgrade
Book Value Per Share
1.551.561.351.750.621.14
Upgrade
Tangible Book Value
1,1021,119969.81,254441.89814.5
Upgrade
Tangible Book Value Per Share
1.531.561.351.750.621.14
Upgrade
Machinery
-143.76143.76140.92148.2153.31
Upgrade
Leasehold Improvements
-60.7160.7160.6758.1158.07
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.